Related Experiment Video
Updated: Mar 21, 2026
Isolation and Cultivation of Mandibular Bone Marrow Mesenchymal Stem Cells in Rats
Published on: August 25, 2020
Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal
Fanbiao Meng1,2, Liangliang Xu2,3, Shuo Huang2
1Health Science Center, Shenzhen University, Shenzhen, China.
Abstract:
Small nuclear ribonucleoprotein-associated polypeptide N mutation in mice is associated with short limbs and lower bone mineral density, yet the role of Sm51 in MSC differentiation to osteoblasts is not known. In the present study, we investigate the role of Sm51 in regulating osteoblastic differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs). Stable overexpression of Sm51 in rat and human BM-MSCs (Sm51-MSCs) significantly enhanced their osteogenic differentiation potential compared to untransfected cells. Under osteogenic induction, Sm51-MSCs had higher alkaline phosphatase (ALP) activity and mineralization ability; the expression of osteogenic genes such as runt-related transcription factor 2 (Runx2), osteocalcin, osteopontin, ALP and type I collagen was significantly upregulated compared to the control BM-MSCs. Furthermore, we show that Sm51 overexpression upregulated Runx2 expression at both the RNA and protein level; Sm51 could bind to Runx2 RNA and regulate its expression. Finally, knocking down Runx2 abolished the promoting effects of Sm51 on osteogenesis in BM-MSCs. These results demonstrate that Sm51 plays an important role in regulating osteogenic differentiation of MSCs through increasing Runx2 expression and that Sm51 may be a potential new therapeutic target for promoting bone formation.
Insights
Small nuclear ribonucleoprotein-associated polypeptide N (Sm51) promotes osteoblast differentiation in mesenchymal stem cells. Sm51 enhances bone formation by upregulating Runx2 expression, suggesting it as a therapeutic target for bone diseases.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Bone Biology
Background:
- Mutations in small nuclear ribonucleoprotein-associated polypeptide N (Sm51) are linked to skeletal abnormalities in mice.
- The specific role of Sm51 in osteoblast differentiation from mesenchymal stem cells (MSCs) remains unclear.
Purpose of the Study:
- To investigate the function of Sm51 in regulating the osteogenic differentiation of bone marrow-derived MSCs (BM-MSCs).
Main Methods:
- Stable overexpression of Sm51 in rat and human BM-MSCs.
- Assessment of osteogenic differentiation markers including alkaline phosphatase (ALP) activity and mineralization.
- Analysis of key osteogenic gene expression (Runx2, osteocalcin, osteopontin, ALP, collagen I).
- Investigation of Sm51's interaction with Runx2 RNA and the effect of Runx2 knockdown.
Main Results:
- Sm51 overexpression significantly enhanced osteogenic differentiation potential in BM-MSCs.
- Sm51-overexpressing cells exhibited higher ALP activity and mineralization.
- Expression of osteogenic genes, including Runx2, was significantly upregulated by Sm51.
- Sm51 directly upregulates Runx2 expression at both RNA and protein levels.
- Knockdown of Runx2 abolished the osteogenic promoting effects of Sm51.
Conclusions:
- Sm51 plays a crucial role in regulating MSC osteogenic differentiation.
- Sm51 promotes osteogenesis by increasing Runx2 expression.
- Sm51 represents a potential therapeutic target for enhancing bone formation.
